Innovative treatment for non-small cell lung cancer patients with ALK+

Innovative treatment for non-small cell lung cancer patients with ALK+

Leading respiratory and oncology experts gathered at a conference to discuss advances in the treatments of non-small cell lung cancer patients with ALK+.
Experts seek to optimise treatment of metastatic HER2 positive breast cancer in Vietnam

Experts seek to optimise treatment of metastatic HER2 positive breast cancer in Vietnam

K Hospital and Roche Vietnam discussed optimising treatment for patients with HER2 positive breast cancer in Vietnam.
Innovative solution for breast cancer patients during COVID-19 pandemic

Innovative solution for breast cancer patients during COVID-19 pandemic

The COVID-19 outbreak has inhibited travel for many cancer patients who require ongoing treatment, especially while many hospitals require social distancing.
Oncology medication disrupted by gridlock

Oncology medication disrupted by gridlock

Cancer patients in Vietnam are still struggling to receive sufficient treatment at hospitals during the ongoing pandemic, triggering questions about possible impacts on suppliers of relevant oncology drugs.
Filling in for missed cancer treatment at hospitals

Filling in for missed cancer treatment at hospitals

With the global health crisis continuing to outbreak in several Asian countries, all focus has been shifted to battling the pandemic, leaving the needs and wants of cancer patients far behind.
Ho Chi Minh City Oncology Hospital joins project on improving breast cancer treatment

Ho Chi Minh City Oncology Hospital joins project on improving breast cancer treatment

Ho Chi Minh City Oncology Hospital, VMA, and Roche Vietnam will improve access to advanced therapies for high-risk breast cancer patients.
Roche improving cancer care in Vietnam through innovative training and therapy

Roche improving cancer care in Vietnam through innovative training and therapy

Public-private collaboration has brought hope for vulnerable patients thanks to new and innovative therapies. Girish Mulye, chief representative of Roche Vietnam, talked to VIR’s Bich Thuy about how Roche makes contributions in such partnerships to increase healthcare access to Vietnamese people.
Novartis programme benefits thousands of Vietnamese cancer patients

Novartis programme benefits thousands of Vietnamese cancer patients

The Vietnam Medical Association, the MoH, Vietnam Social Insurance, and Novartis Vietnam Co., Ltd. reviewed the programme supporting cancer medicines.
Manulife spurs healthy and active living at the 2019 Terry Fox Run

Manulife spurs healthy and active living at the 2019 Terry Fox Run

More than 700 Manulife Vietnam employees, agents, and family members joined the Terry Fox Run for the 17th time to promote active and healthy living.
AI for early warning about liver cancer

AI for early warning about liver cancer

HUST is studying a system to support the diagnosis of liver cancer using AI to analyse ultrasound images and interpret gene data.
UK offers HPV vaccines to boys, aims to stop 100,000 cancer cases

UK offers HPV vaccines to boys, aims to stop 100,000 cancer cases

Some 100,000 cases of cancer could be prevented in Britain in the next 40 years by a vaccine against the human papillomavirus (HPV) that causes cancers of the cervix, mouth, anus and genitals, UK health officials said on Tuesday.
EPA reaffirms no risk to public health from glyphosate

EPA reaffirms no risk to public health from glyphosate

The EPA reaffirmed that there are no risks to public health when glyphosate is used in accordance with its current label and that it is not a carcinogen.
J&J may have known for decades about asbestos in its products

J&J may have known for decades about asbestos in its products

Vietnamese consumers are in a frenzy after J&J was ordered to pay a huge compensation to a cancer patient in California.
Bayer AG’s stock sets seven-year record after favourable court ruling

Bayer AG’s stock sets seven-year record after favourable court ruling

The stock of Bayer AG rose sharply after a tentative ruling on the possible removal of the $250 million punitive award on the company and prompt a new trial.
Cancer to kill 10 million people in 2018 despite better prevention

Cancer to kill 10 million people in 2018 despite better prevention

Cancer will kill nearly 10 million people this year, experts said Wednesday (Sep 12), warning the disease's global burden continues to rise in spite of better prevention and earlier diagnosis.
1 2